Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPaypoint Regulatory News (PAY)

Share Price Information for Paypoint (PAY)

Share Price is delayed by 15 minutes
Get Live Data
545.50    11.50 (2.15%)
Bid:
544.50
Ask:
551.00
Spread: 6.50 (1.194%)
Market Cap: £328.63m
PAY Live PriceLast checked at - London Stock Exchange

Intraday Paypoint Share Chart

Form 8.3 - PAYPOINT PLC

15 Feb 2023 14:24

RNS Number : 0508Q
Barclays PLC
15 February 2023
Β 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Β 

Barclays PLC.

(b)

Owner or controller of interest and short

Β 

Β 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

PAYPOINT PLC

Β 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Β 

Β 

offeror/offeree, state this and specify identity of

Β 

offeror/offeree:

(e)

Date position held/dealing undertaken:

14 Feb 2023

(f)

In addition to the company in 1(c) above, is the discloser making

YES:

Β 

Β 

Β 

disclosures in respect of any other party to the offer?

APPRECIATE GROUP PLC

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Β 

Β 

to which the disclosure relates following the dealing(if any)

Β 

Class of relevant security:

1/3p ordinary

Β 

Interests

Short Positions

Β 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

126,594

0.18%

114,963

0.17%

(2)

Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

297,416

0.43%

100,664

0.15%

(3)

Stock-settled derivatives (including options)

Β 

Β 

Β 

Β 

Β 

and agreements to purchase/sell:

Β 

Β 

0

0.00%

0

0.00%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

Β 

424,010

0.61%

215,627

0.31%

(b)

Rights to subscribe for new securities (including directors and other executive

Β 

Β 

options)

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant security in relation to

Β 

Β 

Β 

Β 

which subscription right exists

Β 

Β 

Β 

Β 

Details, including nature of the rights

Β 

Β 

Β 

Β 

concerned and relevant percentages:

Β 

Β 

Β 

Β 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Β 

Β 

Β 

Β 

Β 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Β 

securities

Β 

1/3p ordinary

Purchase

135

4.9250 GBP

1/3p ordinary

Purchase

150

4.9000 GBP

1/3p ordinary

Purchase

350

4.8976 GBP

1/3p ordinary

Purchase

515

4.9248 GBP

1/3p ordinary

Purchase

621

4.8600 GBP

1/3p ordinary

Sale

135

4.8597 GBP

1/3p ordinary

Sale

150

4.9000 GBP

1/3p ordinary

Sale

160

4.8775 GBP

1/3p ordinary

Sale

216

4.8598 GBP

1/3p ordinary

Sale

461

4.8705 GBP

1/3p ordinary

Sale

608

4.8781 GBP

1/3p ordinary

Sale

632

4.8589 GBP

1/3p ordinary

Sale

1,948

4.9250 GBP

1/3p ordinary

Sale

2,702

4.8600 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Β 

reference

unit

security

Β 

Β 

securities

Β 

1/3p ordinary

SWAP

Long

70

4.9299 GBP

1/3p ordinary

SWAP

Long

163

4.8598 GBP

1/3p ordinary

SWAP

Long

188

4.8597 GBP

1/3p ordinary

SWAP

Long

391

4.8599 GBP

1/3p ordinary

CFD

Long

632

4.8589 GBP

1/3p ordinary

SWAP

Long

1,061

4.9248 GBP

1/3p ordinary

CFD

Long

1,140

4.8929 GBP

1/3p ordinary

SWAP

Long

2,506

4.8600 GBP

1/3p ordinary

CFD

Short

258

4.8600 GBP

1/3p ordinary

SWAP

Short

652

4.8939 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Β 

date

money

relevant

Β 

selling,

securities

per unit

Β 

Β 

paid/

security

Β 

varying etc

to which

Β 

Β 

Β 

received

Β 

Β 

Β 

option

Β 

Β 

Β 

per unit

Β 

Β 

Β 

relates

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercising

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Β 

Β 

securities

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Β 

Β 

applicable)

Β 

Β 

Β 

Β 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding,

Β 

Β 

formal or informal, relating to relevant securities which may be an inducement to deal

Β 

Β 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Β 

to the offer or any person acting in concert with a party to the offer:

Β 

Β 

Β 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between

Β 

Β 

the person making the disclosure and any other person relating to:

Β 

Β 

(i) the voting rights of any relevant securities under any option; or

Β 

Β 

Β 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Β 

Β 

any derivative is referenced:

Β 

Β 

Β 

Β 

Β 

Β 

NONE

(c)

Attachments

Β 

Β 

Β 

Β 

Β 

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

15 Feb 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETZELFFXLLLBBX
Date   Source Headline
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amBUSTotal Voting Rights and Capital
27th May 202610:49 amBUSPayPoint plc : Director/PDMR Shareholding
27th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
7th May 20262:34 pmBUSResolution of claim by Global 365 Limited – Competition Appeal Tribunal Judgment
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:01 amBUSTotal Voting Rights and Capital
29th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20269:19 amBUSPayPoint plc : Director/PDMR Shareholding
22nd Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20261:55 pmBUSHolding(s) in Shares
1st Apr 20267:01 amBUSTotal Voting Rights and Capital
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20264:58 pmBUSPayPoint plc : Director/PDMR Shareholding
31st Mar 202612:39 pmBUSPayPoint plc : Director/PDMR Shareholding
31st Mar 20269:14 amBUSPayPoint plc : Director/PDMR Shareholding
30th Mar 20267:00 amBUSFY26 Update, Business Reorganisation and FY27 Outlook
26th Mar 20265:26 pmBUSDirectorate Change
25th Mar 20264:50 pmBUSPayPoint plc : Director/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:01 amBUSTotal Voting Rights and Capital
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20263:20 pmGNWPayPoint plc : Director/PDMR Shareholding
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.